These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19887580)

  • 21. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.
    Hirasawa H; Tanaka S; Sakai A; Tsutsui M; Shimokawa H; Miyata H; Moriwaki S; Niida S; Ito M; Nakamura T
    J Bone Miner Res; 2007 Jul; 22(7):1020-30. PubMed ID: 17388726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
    Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
    Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.
    Itoh S; Udagawa N; Takahashi N; Yoshitake F; Narita H; Ebisu S; Ishihara K
    Bone; 2006 Sep; 39(3):505-12. PubMed ID: 16679075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide Y expression and function during osteoblast differentiation--insights from transthyretin knockout mice.
    Nunes AF; Liz MA; Franquinho F; Teixeira L; Sousa V; Chenu C; Lamghari M; Sousa MM
    FEBS J; 2010 Jan; 277(1):263-75. PubMed ID: 19954489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing.
    Marsell R; Jonsson KB; Cho TJ; Einhorn TA; Ohlsson C; Schipani E
    Acta Orthop; 2007 Feb; 78(1):39-45. PubMed ID: 17453391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice.
    Notini AJ; McManus JF; Moore A; Bouxsein M; Jimenez M; Chiu WS; Glatt V; Kream BE; Handelsman DJ; Morris HA; Zajac JD; Davey RA
    J Bone Miner Res; 2007 Mar; 22(3):347-56. PubMed ID: 17147488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased trabecular bone formation in mice lacking the growth factor midkine.
    Neunaber C; Catala-Lehnen P; Beil FT; Marshall RP; Kanbach V; Baranowsky A; Lehmann W; Streichert T; Ignatius A; Muramatsu T; Schinke T; Amling M
    J Bone Miner Res; 2010 Aug; 25(8):1724-35. PubMed ID: 20200993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice.
    Sheng MH; Zhou XD; Bonewald LF; Baylink DJ; Lau KH
    Bone; 2013 Jan; 52(1):133-44. PubMed ID: 23032105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
    Govoni KE; Baylink DJ; Chen J; Mohan S
    Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive activation of IKK2/NF-κB impairs osteogenesis and skeletal development.
    Swarnkar G; Zhang K; Mbalaviele G; Long F; Abu-Amer Y
    PLoS One; 2014; 9(3):e91421. PubMed ID: 24618907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function.
    Bentmann A; Kawelke N; Moss D; Zentgraf H; Bala Y; Berger I; Gasser JA; Nakchbandi IA
    J Bone Miner Res; 2010 Apr; 25(4):706-15. PubMed ID: 19821765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
    Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
    Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis.
    Cho HY; Choi HJ; Sun HJ; Yang JY; An JH; Cho SW; Kim SW; Kim SY; Kim JE; Shin CS
    Bone; 2010 Aug; 47(2):263-71. PubMed ID: 20472109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of Lrp5 function in osteoblast progenitors.
    Yadav VK; Arantes HP; Barros ER; Lazaretti-Castro M; Ducy P
    Calcif Tissue Int; 2010 May; 86(5):382-8. PubMed ID: 20333369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nrf2 is a novel regulator of bone acquisition.
    Park CK; Lee Y; Kim KH; Lee ZH; Joo M; Kim HH
    Bone; 2014 Jun; 63():36-46. PubMed ID: 24521946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Runx2 is a target of mechanical unloading to alter osteoblastic activity and bone formation in vivo.
    Salingcarnboriboon R; Tsuji K; Komori T; Nakashima K; Ezura Y; Noda M
    Endocrinology; 2006 May; 147(5):2296-305. PubMed ID: 16455780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization.
    Suh WK; Wang SX; Jheon AH; Moreno L; Yoshinaga SK; Ganss B; Sodek J; Grynpas MD; Mak TW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12969-73. PubMed ID: 15317945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.